Evidence map›Paper›PMID 35697834›Full record

ArticleNature methods2022

Direct identification of A-to-I editing sites with nanopore native RNA sequencing.

Tram Anh Nguyen, Jia Wei Joel Heng, Pornchai Kaewsapsak, Eng Piew Louis Kok, Dominik Stanojević, Hao Liu, Angelysia Cardilla, Albert Praditya, Zirong Yi, Mingwan Lin and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 132 citations in OpenAlex.

  1. Epitranscriptomic Analysis of A-to-I RNA Editing and mInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 2 institutions in 5 countries.

Tram Anh NguyenSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4275-3858
Jia Wei Joel Heng *School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0002-8853-9355
Pornchai Kaewsapsak *Genome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.
Eng Piew Louis KokGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.
Dominik StanojevićGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.
Hao LiuSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Angelysia CardillaSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Albert PradityaSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Zirong YiSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Mingwan LinGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4562-5026
Jong Ghut Ashley AwGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.
Yin Ying HoBioprocessing Technology Institute, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-5154-9605
Kai Lay Esther PehBioprocessing Technology Institute, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0001-5622-8870
Yuanming WangSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Qixing ZhongGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.
Jacki Heraud-FarlowSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia.ORCID http://orcid.org/0000-0002-3786-8474
Shifeng XueInstitute of Molecular and Cell Biology, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4668-5952
Bruno ReversadeGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4070-7997
Carl WalkleySt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia.ORCID http://orcid.org/0000-0002-4784-9031
Ying Swan HoBioprocessing Technology Institute, Agency for Science Technology and Research, Singapore, Singapore.
Mile ŠikićGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-8370-0891
Yue WanGenome Institute of Singapore, Agency for Science Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-2433-9637
Meng How TanSchool of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore. mh.tan@ntu.edu.sg.ORCID http://orcid.org/0000-0003-3627-5586
Agency for Science, Technology and Research · SGThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inosine is a prevalent RNA modification in animals and is formed when an adenosine is deaminated by the ADAR family of enzymes. Traditionally, inosines are identified indirectly as variants from Illumina RNA-sequencing data because they are interpreted as guanosines by cellular machineries. However, this indirect method performs poorly in protein-coding regions where exons are typically short, in non-model organisms with sparsely annotated single-nucleotide polymorphisms, or in disease contexts where unknown DNA mutations are pervasive. Here, we show that Oxford Nanopore direct RNA sequencing can be used to identify inosine-containing sites in native transcriptomes with high accuracy. We trained convolutional neural network models to distinguish inosine from adenosine and guanosine, and to estimate the modification rate at each editing site. Furthermore, we demonstrated their utility on the transcriptomes of human, mouse and Xenopus. Our approach expands the toolkit for studying adenosine-to-inosine editing and can be further extended to investigate other RNA modifications.

Indexed as

NanoporesRNAAdenosineAnimalsInosineMiceRNA EditingSequence Analysis, RNAAdenosineInosineRNA

Identifiers

PMID35697834
OpenAlexW4282585897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.